Merck Immunotherapy Drug Shines In Lung Cancer Study
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
Read more on NPR
Health Care
April 17, 2018 at 04:43AM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét